John K Camoriano, MD

  • 2618 Citations
  • 27 Scopus h-Index
1982 …2018
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1982 2018

  • 2618 Citations
  • 27 Scopus h-Index
  • 46 Article
  • 2 Letter
Filter
Article
2018

PET/TC con 18F-FDG en la detección de adenocarcinoma oculto de vesícula biliar que se presenta como tumores de Krukenberg ováricos bilaterales

Translated title of the contribution: 18F-FDG PET/CT in detection of occult gallbladder adenocarcinoma presenting as bilateral ovarian Krukenberg tumorsJamison, D. K., Butler, K. A., Stucky, C. C. H., Camoriano, J. K. & Yang, M., Jan 1 2018, (Accepted/In press) In : Revista Espanola de Medicina Nuclear e Imagen Molecular.

Research output: Contribution to journalArticle

Krukenberg Tumor
Fluorodeoxyglucose F18
Gallbladder
Adenocarcinoma
2017
5 Citations (Scopus)

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
Lymphoma
B-Cell Lymphoma
11 Citations (Scopus)

Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis

Gowin, K., Kosiorek, H., Dueck, A., Mascarenhas, J., Hoffman, R., Reeder, C., Camoriano, J. K., Tibes, R., Gano, K., Palmer, J. & Mesa, R., Sep 1 2017, In : Leukemia Research. 60, p. 31-35 5 p.

Research output: Contribution to journalArticle

Danazol
Primary Myelofibrosis
Splenomegaly
Therapeutics
Anemia
8 Citations (Scopus)

Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial

Gowin, K., Jain, T., Kosiorek, H., Tibes, R., Camoriano, J. K., Palmer, J. & Mesa, R., Mar 1 2017, In : Leukemia Research. 54, p. 73-77 5 p.

Research output: Contribution to journalArticle

Clinical Trials
Thrombocytosis
Neoplasms
Polycythemia Vera
Primary Myelofibrosis
2014
76 Citations (Scopus)

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies

Bogenberger, J. M., Kornblau, S. M., Pierceall, W. E., Lena, R., Chow, D., Shi, C. X., Mantei, J., Ahmann, G., Gonzales, I. M., Choudhary, A., Valdez, R., Camoriano, J. K., Fauble, V., Tiedemann, R. E., Qiu, Y. H., Coombes, K. R., Cardone, M., Braggio, E. D., Yin, H., Azorsa, D. O. & 3 others, Mesa, R. A., Stewart, A. K. & Tibes, R., 2014, In : Leukemia. 28, 8, p. 1657-1665 9 p.

Research output: Contribution to journalArticle

Azacitidine
Neoplasms
Proteins
RNA Interference
Small Interfering RNA
1 Citation (Scopus)

Interferon-α and pericardial injury: A case report and literature review

Hakim, F. A., Singh, S., Pandit, A., Alegria, J. R., Camoriano, J. K., Stanton, M. L. & Mookadam, F., 2014, In : Heart Asia. 6, 1, p. 48-53 6 p.

Research output: Contribution to journalArticle

Interferons
Wounds and Injuries
Pericarditis
Pericardial Effusion
Constriction
50 Citations (Scopus)

Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia

Ghobrial, I. M., Witzig, T. E., Gertz, M., Laplant, B., Hayman, S., Camoriano, J. K., Lacy, M., Bergsagel, P. L., Chuma, S., Deangelo, D. & Treon, S. P., Mar 2014, In : American Journal of Hematology. 89, 3, p. 237-242 6 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Disease-Free Survival
Raptors
Stomatitis
Leukopenia
17 Citations (Scopus)

Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

Geyer, H., Cannon, K., Knight, E., Fauble, V., Camoriano, J. K., Emanuel, R., Tibes, R. & Mesa, R., Jan 2014, In : Leukemia and Lymphoma. 55, 1, p. 195-197 3 p.

Research output: Contribution to journalArticle

Pyrazoles
Janus Kinases
Drug Approval
Primary Myelofibrosis
United States Food and Drug Administration
2012
30 Citations (Scopus)

Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase

Cherington, C., Slack, J. L., Leis, J., Adams, R. H., Reeder, C. B., Mikhael, J. R., Camoriano, J. K., Noel, P., Fauble, V., Betcher, J., Higgins, M. S., Gillette-Kent, G., Tremblay, L. D., Peterson, M. E., Olsen, J. J., Tibes, R. & Mesa, R. A., Sep 2012, In : Leukemia Research. 36, 9, p. 1147-1151 5 p.

Research output: Contribution to journalArticle

Blast Crisis
Stem Cell Transplantation
Neoplasms
Bone Marrow
Leukemia
15 Citations (Scopus)

A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma

Wahner Hendrickson, A. E., Oberg, A. L., Glaser, G., Camoriano, J. K., Peethambaram, P. P., Colon-Otero, G., Erlichman, C., Ivy, S. P., Kaufmann, S. H., Karnitz, L. M. & Haluska, P., Feb 2012, In : Gynecologic Oncology. 124, 2, p. 210-215 6 p.

Research output: Contribution to journalArticle

tanespimycin
gemcitabine
Carcinoma
Blood Cells
Neoplasms
56 Citations (Scopus)

Experience with pegylated interferon α -2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients

Gowin, K., Thapaliy, P., Samuelson, J., Harrison, C., Radia, D., Andreasson, B., Mascarenhas, J., Rambaldi, A., Barbui, T., Rea, C. J., Camoriano, J. K., Gentry, A., Kiladjian, J. J., O'Connell, C. & Mesa, R., Oct 1 2012, In : Haematologica. 97, 10, p. 1570-1573 4 p.

Research output: Contribution to journalArticle

Interferons
Neoplasms
Essential Thrombocythemia
Thrombocytosis
Polycythemia Vera
11 Citations (Scopus)

Gemcitabine and docetaxel for hepatocellular carcinoma: A phase II north central cancer treatment group clinical trial

Alberts, S. R., Reid, J. M., Morlan, B. W., Farr, G. H., Camoriano, J. K., Johnson, D. B., Enger, J. R., Seay, T. E. & Kim, G. P., Oct 2012, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 35, 5, p. 418-423 6 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Hepatocellular Carcinoma
Clinical Trials
Neoplasms
103 Citations (Scopus)

The clinical spectrum of Castleman's disease

Dispenzieri, A., Armitage, J. O., Loe, M. J., Geyer, S. M., Allred, J., Camoriano, J. K., Menke, D. M., Weisenburger, D. D., Ristow, K., Dogan, A. & Habermann, T. M., Nov 2012, In : American Journal of Hematology. 87, 11, p. 997-1002 6 p.

Research output: Contribution to journalArticle

POEMS Syndrome
Giant Lymph Node Hyperplasia
Survival
Multi-centric Castleman's Disease
2011
31 Citations (Scopus)
Primary Myelofibrosis
Thalidomide
Prednisone
Cohort Studies
Retrospective Studies
2010
1 Citation (Scopus)

Paraneoplastic polymyositis associated with mesothelioma: A brief report

Schuster, S. R., Burnette, B. L., de Petr, G., Harmon, C. E., Camoriano, J. K. & Ross, H. J., Apr 2010, In : Community Oncology. 7, 4, p. 178-180 3 p.

Research output: Contribution to journalArticle

Polymyositis
Myositis
Mesothelioma
Paraneoplastic Syndromes
Asbestos
107 Citations (Scopus)

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory waldenström macroglobulinemia

Ghobrial, I. M., Gertz, M., LaPlant, B., Camoriano, J. K., Hayman, S., Lacy, M., Chuma, S., Harris, B., Leduc, R., Rourke, M., Ansell, S. M., DeAngelo, D., Dispenzieri, A., Bergsagel, P. L., Reeder, C., Anderson, K. C., Richardson, P. G., Treon, S. P. & Witzig, T. E., Mar 10 2010, In : Journal of Clinical Oncology. 28, 8, p. 1408-1414 7 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Sirolimus
Disease-Free Survival
Everolimus
Phosphatidylinositol 3-Kinase
2009
138 Citations (Scopus)

The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

Mesa, R. A., Schwager, S., Radia, D., Cheville, A. L., Hussein, K., Niblack, J., Pardanani, A. D., Steensma, D. P., Litzow, M. R., Rivera, C. E., Camoriano, J. K., Verstovsek, S., Sloan, J. A., Harrison, C., Kantarjian, H. & Tefferi, A., Sep 2009, In : Leukemia Research. 33, 9, p. 1199-1203 5 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Symptom Assessment
Quality of Life
Equipment and Supplies
Therapeutics
2008
57 Citations (Scopus)

Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): Results of a large internet-based survey

Steensma, D. P., Heptinstall, K. V., Johnson, V. M., Novotny, P. J., Sloan, J. A., Camoriano, J. K., Niblack, J., Bennett, J. M. & Mesa, R. A., May 2008, In : Leukemia Research. 32, 5, p. 691-698 8 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Internet
Quality of Life
Fatigue
Hemoglobins
2007
32 Citations (Scopus)

A phase II trial of tipifarnib in myelofibrosis: Primary, post-polycythemia vera and post-essential thrombocythemia

Mesa, R. A., Camoriano, J. K., Geyer, S. M., Wu, W., Kaufmann, S. H., Rivera, C. E., Erlichman, C., Wright, J., Pardanani, A. D., Lasho, T., Finke, C., Li, C. Y. & Tefferi, A., Sep 2007, In : Leukemia. 21, 9, p. 1964-1970 7 p.

Research output: Contribution to journalArticle

tipifarnib
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Farnesyltranstransferase
8 Citations (Scopus)

Clearance of the Janus Kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia

Ruiz-Argüelles, G. J., Garcés-Eisele, J., Reyes-Núñez, V., Ruiz-Delgado, G. J., Rosillo, C. & Camoriano, J. K., May 2007, In : American Journal of Hematology. 82, 5, p. 400-402 3 p.

Research output: Contribution to journalArticle

Janus Kinase 2
Primary Myelofibrosis
Stem Cell Transplantation
Mutation
Genes
54 Citations (Scopus)

Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: Results of the north central cancer treatment group phase II study N9942

Haddock, M., Swaminathan, R., Foster, N. R., Hauge, M. D., Martenson, J. A., Camoriano, J. K., Stella, P. J., Tenglin, R. C., Schaefer, P. L., Moore, D. F. & Alberts, S. R., Jun 20 2007, In : Journal of Clinical Oncology. 25, 18, p. 2567-2572 6 p.

Research output: Contribution to journalArticle

gemcitabine
Cisplatin
Adenocarcinoma
Radiotherapy
Neoplasms
233 Citations (Scopus)

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): An international internet-based survey of 1179 MPD patients

Mesa, R. A., Niblack, J., Wadleigh, M., Verstovsek, S., Camoriano, J. K., Barnes, S., Tan, A. D., Atherton, P. J., Sloan, J. A. & Tefferi, A., Jan 1 2007, In : Cancer. 109, 1, p. 68-76 9 p.

Research output: Contribution to journalArticle

Myeloproliferative Disorders
Internet
Fatigue
Quality of Life
Exercise
7 Citations (Scopus)
Phase II Clinical Trials
Proxy
Hepatocellular Carcinoma
DNA
Neoplasms
2006
15 Citations (Scopus)

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

Delaunoit, T., Burch, P. A., Reid, J. M., Camoriano, J. K., Kobayash, T., Braich, T. A., Kaur, J. S., Rubin, J. & Erlichman, C., Jul 2006, In : Investigational New Drugs. 24, 4, p. 327-333 7 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Neoplasms
Neutropenia
Half-Life
Cytidine Deaminase
106 Citations (Scopus)

FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature

Pardanani, A. D., Ketterling, R. P., Li, C. Y., Patnaik, M. M., Wolanskyj, A. P., Elliott, M. A., Camoriano, J. K., Butterfield, J. H., Dewald, G. W. & Tefferi, A., Aug 2006, In : Leukemia Research. 30, 8, p. 965-970 6 p.

Research output: Contribution to journalArticle

Eosinophilia
Therapeutics
Mutation
Imatinib Mesylate
Appointments and Schedules
113 Citations (Scopus)

Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North central cancer treatment group trial N0032

Ingle, J. N., Suman, V. J., Rowland, K. M., Mirchandani, D., Bernath, A. M., Camoriano, J. K., Fishkin, P. A. S., Nikcevich, D. A. & Perez, E. A., Mar 1 2006, In : Journal of Clinical Oncology. 24, 7, p. 1052-1056 5 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Breast Neoplasms
Neoplasms
Therapeutics
Disease Progression
260 Citations (Scopus)

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)

Tefferi, A., Barosi, G., Mesa, R. A., Cervantes, F., Deeg, H. J., Reilly, J. T., Verstovsek, S., Dupriez, B., Silver, R. T., Odenike, O., Cortes, J., Wadleigh, M., Solberg, L. A., Camoriano, J. K., Gisslinger, H., Noel, P., Thiele, J., Vardiman, J. W., Hoffman, R., Cross, N. C. P. & 2 others, Gilliland, D. G. & Kantarjian, H., Sep 1 2006, In : Blood. 108, 5, p. 1497-1503 7 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Stem cells
Consensus
Bone
Research
2004

The Office of Advanced Technology: providing focus on the piloting and implementation of new technology.

Bobis, K. G., Camoriano, J. K. & Wright, M. J., 2004, In : Journal of healthcare information management : JHIM. 18, 4, p. 27-32 6 p.

Research output: Contribution to journalArticle

Technology
Medical Informatics
Nurses
Physicians
2003
1 Citation (Scopus)

Managing technology in a physician-led organization.

Bobis, K. G. & Camoriano, J. K., 2003, In : Journal of healthcare information management : JHIM. 17, 2, p. 24-31 8 p.

Research output: Contribution to journalArticle

Organizations
Technology
Physicians
Electronic Health Records
Practice Management
2002
63 Citations (Scopus)

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

Tefferi, A., Mesa, R. A., Gray, L. A., Steensma, D. P., Camoriano, J. K., Elliott, M. A., Pardanani, A. D., Ansell, S. M., Call, T. G., Colon-Otero, G., Schroeder, G., Hanson, C. A., Dewald, G. W. & Kaufmann, S. H., May 15 2002, In : Blood. 99, 10, p. 3854-3856 3 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Platelets
Platelet Count
Imatinib Mesylate
Gilbert Disease
2000
51 Citations (Scopus)

Phase II study of paclitaxel and cisplatin for advanced urothelial cancer

Burch, P. A., Richardson, R. L., Cha, S. S., Sargent, D. J., Pitot, H. C., Kaur, J. S. & Camoriano, J. K., 2000, In : Journal of Urology. 164, 5, p. 1538-1542 5 p.

Research output: Contribution to journalArticle

Neoplasms
Leukopenia
Anorexia
Paclitaxel
Thrombocytopenia
1999
25 Citations (Scopus)

Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura

Harold, K. L., Schlinkert, R. T., Mann, D. K., Reeder, C. B., Noel, P., Fitch, T. R., Braich, T. A. & Camoriano, J. K., 1999, In : Mayo Clinic Proceedings. 74, 1, p. 37-39 3 p.

Research output: Contribution to journalArticle

Idiopathic Thrombocytopenic Purpura
Splenectomy
Conversion to Open Surgery
Platelet Count
Pancreatitis
250 Citations (Scopus)

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., Krook, J. E., Wilwerding, M. B., Rowland, K. M., Camoriano, J. K., Novotny, P. J. & Christensen, B. J., Oct 1999, In : Journal of Clinical Oncology. 17, 10, p. 3299-3306 8 p.

Research output: Contribution to journalArticle

Fluoxymesterone
Megestrol Acetate
Cachexia
Anorexia
Dexamethasone
1998
3 Citations (Scopus)
Granulocyte Colony-Stimulating Factor
Non-Hodgkin's Lymphoma
Prednisone
Neutropenia
S Phase
1997
2 Citations (Scopus)
Vinblastine
Granulocyte Colony-Stimulating Factor
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
Cisplatin
53 Citations (Scopus)

A randomized phase II trial of two dosage levels of letrozole as third- line hormonal therapy for women with metastatic breast carcinoma

Ingle, J. N., Johnson, P. A., Suman, V. J., Gerstner, J. B., Mailliard, J. A., Camoriano, J. K., Gesme, D. H., Loprinzi, C. L., Hatfield, A. K. & Hartmann, L. C., Jul 15 1997, In : Cancer. 80, 2, p. 218-224 7 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Therapeutics
Aromatase Inhibitors
Disease Progression
2 Citations (Scopus)
Carboplatin
Etoposide
Combination Drug Therapy
Cisplatin
Neoplasms
62 Citations (Scopus)

Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy

Loprinzi, C. L., Ghosh, C., Camoriano, J. K., Sloan, J. A., Steen, P. D., Michalak, J. C., Schaefer, P. L., Novotny, P. J., Gerstner, J. B., White, D. F., Hatfield, A. K. & Quella, S. K., Mar 1997, In : Journal of Clinical Oncology. 15, 3, p. 1235-1238 4 p.

Research output: Contribution to journalArticle

Sucralfate
Stomatitis
Fluorouracil
Drug Therapy
Mouth
1996
83 Citations (Scopus)

Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies

Menke, D. M., Tiemann, M., Camoriano, J. K., Chang, S. F., Madan, A., Chow, M., Habermann, T. M. & Parwaresch, R., Mar 1996, In : American Journal of Clinical Pathology. 105, 3, p. 268-276 9 p.

Research output: Contribution to journalArticle

Giant Lymph Node Hyperplasia
Paraffin
B-Lymphocytes
Lymph Nodes
Biopsy
29 Citations (Scopus)

Malignant fibrous histiocytoma of the lung: Report of four cases and review of the literature

Halyard, M. Y., Camoriano, J. K., Culligan, J. A., Weiland, L. H., Allen, M. S., Pluth, J. R. & Pairolero, P. C., Dec 15 1996, In : Cancer. 78, 12, p. 2492-2497 6 p.

Research output: Contribution to journalArticle

Malignant Fibrous Histiocytoma
Lung
Radiotherapy
Drug Therapy
Recurrence
1994
7 Citations (Scopus)

Thoracoscopic excision of a peripheral corticotropin-secreting pulmonary carcinoid tumor

Gharagozloo, F., Dausmann, M. J., Whitaker, M. D., Camoriano, J. K., Parish, J. M., McReynolds, S. D., Hall, K. A. & Pluth, J. R., 1994, In : Mayo Clinic Proceedings. 69, 6, p. 594-596 3 p.

Research output: Contribution to journalArticle

Carcinoid Tumor
Adrenocorticotropic Hormone
Lung
Thoracoscopy
Cushing Syndrome
1992
73 Citations (Scopus)
Giant Lymph Node Hyperplasia
Hyalin
Plasma Cells
Blood Vessels
Steroids
1990
206 Citations (Scopus)

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer

Camoriano, J. K., Loprinzi, C. L., Ingle, J. N., Therneau, T. M., Krook, J. E. & Veeder, M. H., 1990, In : Journal of Clinical Oncology. 8, 8, p. 1327-1334 8 p.

Research output: Contribution to journalArticle

Mastectomy
Breast Neoplasms
Weights and Measures
Recurrence
Adjuvant Chemotherapy
1989
18 Citations (Scopus)

Acquired divergent strabismus: Presumed metastatic gastric carcinoma to the medial rectus muscle

Arnold, R. W., Adams, B. A., Camoriano, J. K. & Dyer, J. A., 1989, In : Journal of Pediatric Ophthalmology and Strabismus. 26, 1, p. 50-51 2 p.

Research output: Contribution to journalArticle

Exotropia
Oculomotor Muscles
Stomach
Neoplasm Metastasis
Carcinoma
65 Citations (Scopus)

Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome

Sodhi, N., Camilleri, M., Camoriano, J. K., Low, P. A., Fealey, R. D. & Perry, M. C., Dec 1989, In : Digestive Diseases and Sciences. 34, 12, p. 1937-1942 6 p.

Research output: Contribution to journalArticle

Intestinal Pseudo-Obstruction
Paraneoplastic Syndromes
Edrophonium
Gastrointestinal Motility
Small Cell Lung Carcinoma
1987
41 Citations (Scopus)

Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy

Camoriano, J. K., Greipp, P. R., Bayer, G. K. & Bowie, E. J. W., 1987, In : New England Journal of Medicine. 316, 18, p. 1133-1135 3 p.

Research output: Contribution to journalArticle

Factor X Deficiency
Hypoprothrombinemias
Melphalan
Amyloidosis
Prednisone